Long-term effectiveness of verapamil in stable and unstable angina pectoris. One-year follow-up of patients treated in placebo-controlled double-blind randomized clinical trials

Stephen Scheidt, William H. Frishman, Milton Packer, Jawahar Mehta, Oberdan Parodi, V. Bala Subramanian

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The clinical responses to 12 months' treatment with verapamfl were evaluated in 63 patients with stable and unstable angina pectoris in whom the effectiveness of verapamil had been established in short-term double-blind placebo-controlled randomized clinical trials. In 41 patients with effort-related angina, long-term responses were sustained for periods exceeding 1 year. Twenty patients were evaluated by clinical history and showed a sustained reduction in frequency of anginal attacks and consumption of nitroglycerln with verapamil compared with the initial placebo control periods; the magnitude of this benefit was similar to that observed during doubleblind treatment with the drug. Twenty-one patients were evaluated by serial treadmill exercise testing and showed a sustained improvement in exercise duration after 4, 8, 16, 24, and 52 weeks of verapamil treatment; withdrawal of the drug resulted in a deterioration of exercise performance to levels similar to those seen before initiation of therapy. In 22 patients with unstable angina at rest, verapamil produced an amelioration of anginal symptoms that was sustained in most patients for longer than 1 year. However, these patients continued to have a high incidence of death and myocardial infarction in a frequency similar to that previously reported in large clinical studies using either combinations of verapamil and nitrates, nifedlpine and propranolol, or propranolol and nitrates. Calciumchannel antagonists may decrease the number of patients requiring coronary artery bypass surgery for relief of refractory angina, but they do not appear to alter the natural history of the disease.

Original languageEnglish (US)
Pages (from-to)1185-1190
Number of pages6
JournalThe American Journal of Cardiology
Volume50
Issue number5
DOIs
StatePublished - 1982

Fingerprint

Stable Angina
Unstable Angina
Verapamil
Randomized Controlled Trials
Placebos
Exercise
Propranolol
Nitrates
Therapeutics
Coronary Artery Bypass
Pharmaceutical Preparations
Myocardial Infarction
Incidence

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Long-term effectiveness of verapamil in stable and unstable angina pectoris. One-year follow-up of patients treated in placebo-controlled double-blind randomized clinical trials. / Scheidt, Stephen; Frishman, William H.; Packer, Milton; Mehta, Jawahar; Parodi, Oberdan; Subramanian, V. Bala.

In: The American Journal of Cardiology, Vol. 50, No. 5, 1982, p. 1185-1190.

Research output: Contribution to journalArticle

Scheidt, Stephen ; Frishman, William H. ; Packer, Milton ; Mehta, Jawahar ; Parodi, Oberdan ; Subramanian, V. Bala. / Long-term effectiveness of verapamil in stable and unstable angina pectoris. One-year follow-up of patients treated in placebo-controlled double-blind randomized clinical trials. In: The American Journal of Cardiology. 1982 ; Vol. 50, No. 5. pp. 1185-1190.
@article{ac6a6d029cdb4c87a3a2d70fefcaad1c,
title = "Long-term effectiveness of verapamil in stable and unstable angina pectoris. One-year follow-up of patients treated in placebo-controlled double-blind randomized clinical trials",
abstract = "The clinical responses to 12 months' treatment with verapamfl were evaluated in 63 patients with stable and unstable angina pectoris in whom the effectiveness of verapamil had been established in short-term double-blind placebo-controlled randomized clinical trials. In 41 patients with effort-related angina, long-term responses were sustained for periods exceeding 1 year. Twenty patients were evaluated by clinical history and showed a sustained reduction in frequency of anginal attacks and consumption of nitroglycerln with verapamil compared with the initial placebo control periods; the magnitude of this benefit was similar to that observed during doubleblind treatment with the drug. Twenty-one patients were evaluated by serial treadmill exercise testing and showed a sustained improvement in exercise duration after 4, 8, 16, 24, and 52 weeks of verapamil treatment; withdrawal of the drug resulted in a deterioration of exercise performance to levels similar to those seen before initiation of therapy. In 22 patients with unstable angina at rest, verapamil produced an amelioration of anginal symptoms that was sustained in most patients for longer than 1 year. However, these patients continued to have a high incidence of death and myocardial infarction in a frequency similar to that previously reported in large clinical studies using either combinations of verapamil and nitrates, nifedlpine and propranolol, or propranolol and nitrates. Calciumchannel antagonists may decrease the number of patients requiring coronary artery bypass surgery for relief of refractory angina, but they do not appear to alter the natural history of the disease.",
author = "Stephen Scheidt and Frishman, {William H.} and Milton Packer and Jawahar Mehta and Oberdan Parodi and Subramanian, {V. Bala}",
year = "1982",
doi = "10.1016/0002-9149(82)90441-6",
language = "English (US)",
volume = "50",
pages = "1185--1190",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Long-term effectiveness of verapamil in stable and unstable angina pectoris. One-year follow-up of patients treated in placebo-controlled double-blind randomized clinical trials

AU - Scheidt, Stephen

AU - Frishman, William H.

AU - Packer, Milton

AU - Mehta, Jawahar

AU - Parodi, Oberdan

AU - Subramanian, V. Bala

PY - 1982

Y1 - 1982

N2 - The clinical responses to 12 months' treatment with verapamfl were evaluated in 63 patients with stable and unstable angina pectoris in whom the effectiveness of verapamil had been established in short-term double-blind placebo-controlled randomized clinical trials. In 41 patients with effort-related angina, long-term responses were sustained for periods exceeding 1 year. Twenty patients were evaluated by clinical history and showed a sustained reduction in frequency of anginal attacks and consumption of nitroglycerln with verapamil compared with the initial placebo control periods; the magnitude of this benefit was similar to that observed during doubleblind treatment with the drug. Twenty-one patients were evaluated by serial treadmill exercise testing and showed a sustained improvement in exercise duration after 4, 8, 16, 24, and 52 weeks of verapamil treatment; withdrawal of the drug resulted in a deterioration of exercise performance to levels similar to those seen before initiation of therapy. In 22 patients with unstable angina at rest, verapamil produced an amelioration of anginal symptoms that was sustained in most patients for longer than 1 year. However, these patients continued to have a high incidence of death and myocardial infarction in a frequency similar to that previously reported in large clinical studies using either combinations of verapamil and nitrates, nifedlpine and propranolol, or propranolol and nitrates. Calciumchannel antagonists may decrease the number of patients requiring coronary artery bypass surgery for relief of refractory angina, but they do not appear to alter the natural history of the disease.

AB - The clinical responses to 12 months' treatment with verapamfl were evaluated in 63 patients with stable and unstable angina pectoris in whom the effectiveness of verapamil had been established in short-term double-blind placebo-controlled randomized clinical trials. In 41 patients with effort-related angina, long-term responses were sustained for periods exceeding 1 year. Twenty patients were evaluated by clinical history and showed a sustained reduction in frequency of anginal attacks and consumption of nitroglycerln with verapamil compared with the initial placebo control periods; the magnitude of this benefit was similar to that observed during doubleblind treatment with the drug. Twenty-one patients were evaluated by serial treadmill exercise testing and showed a sustained improvement in exercise duration after 4, 8, 16, 24, and 52 weeks of verapamil treatment; withdrawal of the drug resulted in a deterioration of exercise performance to levels similar to those seen before initiation of therapy. In 22 patients with unstable angina at rest, verapamil produced an amelioration of anginal symptoms that was sustained in most patients for longer than 1 year. However, these patients continued to have a high incidence of death and myocardial infarction in a frequency similar to that previously reported in large clinical studies using either combinations of verapamil and nitrates, nifedlpine and propranolol, or propranolol and nitrates. Calciumchannel antagonists may decrease the number of patients requiring coronary artery bypass surgery for relief of refractory angina, but they do not appear to alter the natural history of the disease.

UR - http://www.scopus.com/inward/record.url?scp=0020382988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020382988&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(82)90441-6

DO - 10.1016/0002-9149(82)90441-6

M3 - Article

C2 - 6814226

AN - SCOPUS:0020382988

VL - 50

SP - 1185

EP - 1190

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 5

ER -